USFDA Approval

Gland Pharma Launches USFDA Approved Sugammadex Injection in 1.6 Billion Dollar US Market

Gland Pharma launches USFDA-approved Sugammadex Injection vials, targeting a USD 1.6 billion US market for the reversal of surgical neuromuscular blockade now.

Gland Pharma · 29 Jul 2026, 11:39 AM IST